Ad is loading...
EMITF
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
11 days until earnings call
KLYG
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

EMITF vs KLYG

Header iconEMITF vs KLYG Comparison
Open Charts EMITF vs KLYGBanner chart's image
Elbit Imaging
Price$1.01
Change-$0.00 (-0.00%)
Volume$1.66K
CapitalizationN/A
Kelyniam Global
Price$0.20
Change-$0.00 (-0.00%)
Volume$20.1K
CapitalizationN/A
EMITF vs KLYG Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMITF vs. KLYG commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMITF is a Hold and KLYG is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (EMITF: $1.01 vs. KLYG: $0.20)
Brand notoriety: EMITF and KLYG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EMITF: 61% vs. KLYG: 143%
Market capitalization -- EMITF: $11.9M vs. KLYG: $2.05M
EMITF [@Medical Specialties] is valued at $11.9M. KLYG’s [@Medical Specialties] market capitalization is $2.05M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EMITF’s FA Score shows that 1 FA rating(s) are green whileKLYG’s FA Score has 2 green FA rating(s).

  • EMITF’s FA Score: 1 green, 4 red.
  • KLYG’s FA Score: 2 green, 3 red.
According to our system of comparison, KLYG is a better buy in the long-term than EMITF.

Price Growth

EMITF (@Medical Specialties) experienced а 0.00% price change this week, while KLYG (@Medical Specialties) price change was +34.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

EMITF is expected to report earnings on Nov 29, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
EMITF($11.9M) has a higher market cap than KLYG($2.05M). KLYG YTD gains are higher at: 220.226 vs. EMITF (-3.810).
EMITFKLYGEMITF / KLYG
Capitalization11.9M2.05M580%
EBITDA-294KN/A-
Gain YTD-3.810220.226-2%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
EMITF vs KLYG: Fundamental Ratings
EMITF
KLYG
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
8364
SMR RATING
1..100
862
PRICE GROWTH RATING
1..100
5634
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EMITF's Valuation (1) in the Real Estate Development industry is significantly better than the same rating for KLYG (72) in the null industry. This means that EMITF’s stock grew significantly faster than KLYG’s over the last 12 months.

KLYG's Profit vs Risk Rating (64) in the null industry is in the same range as EMITF (83) in the Real Estate Development industry. This means that KLYG’s stock grew similarly to EMITF’s over the last 12 months.

KLYG's SMR Rating (2) in the null industry is significantly better than the same rating for EMITF (86) in the Real Estate Development industry. This means that KLYG’s stock grew significantly faster than EMITF’s over the last 12 months.

KLYG's Price Growth Rating (34) in the null industry is in the same range as EMITF (56) in the Real Estate Development industry. This means that KLYG’s stock grew similarly to EMITF’s over the last 12 months.

KLYG's P/E Growth Rating (7) in the null industry is significantly better than the same rating for EMITF (100) in the Real Estate Development industry. This means that KLYG’s stock grew significantly faster than EMITF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GUBGX15.25-0.07
-0.46%
Victory RS International A
FGRSX36.69-0.29
-0.78%
Federated Hermes Intl Leaders R6
NSMRX37.87-0.35
-0.92%
Nuveen Small/Mid-Cap Value I
VSMPX265.08-3.50
-1.30%
Vanguard Total Stock Mkt Idx Instl Pls
USBOX24.37-0.35
-1.42%
Pear Tree Quality Ordinary

EMITF and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMITF has been loosely correlated with HTLZF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EMITF jumps, then HTLZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMITF
1D Price
Change %
EMITF100%
N/A
HTLZF - EMITF
40%
Loosely correlated
+0.31%
AVHHL - EMITF
26%
Poorly correlated
N/A
KLYG - EMITF
24%
Poorly correlated
N/A
ASAPF - EMITF
24%
Poorly correlated
+0.66%
IQV - EMITF
23%
Poorly correlated
-5.06%
More

KLYG and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLYG has been loosely correlated with HTLZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if KLYG jumps, then HTLZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLYG
1D Price
Change %
KLYG100%
N/A
HTLZF - KLYG
37%
Loosely correlated
+0.31%
OSSUY - KLYG
34%
Loosely correlated
N/A
ALC - KLYG
24%
Poorly correlated
-0.05%
EMITF - KLYG
24%
Poorly correlated
N/A
SENS - KLYG
21%
Poorly correlated
-0.18%
More